. Author manuscript; available in PMC: 2019 Feb 1.

Published in final edited form as: J Neurovirol. 2017 Oct 23;24(1):28–40. doi: 10.1007/s13365-017-0591-3

Table 2.

Biochemical, cytological, and virological characteristics of the CSF in HIV-positive, uninfected volunteers and Alzheimer’s disease participants. Significant differences are highlighted in bold.

	HIV+ (n = 68)	HIV- (n = 18)	AD (n=24)	P
WBC, cells/mm³	2.1 (0.6; 7.2)	2 (1;2.5)	0.6(0.3;1.4)	0.0025
WBC count > 5 cells/mm³, n(%)	20 (29)	0	0	-
Glucose, mg/dL	57 (53; 62)	63.5 (59; 71)	60.5(54.0;72.5)	0.0009
Total protein, mg/dL	40 (32; 46)	30.5 (26.5; 38)	37.35(30.7;49.0)	0.0129
Total protein > 45 mg/dL, n(%)	20 (29)	0	7 (29)	0.0302
Albumin, mg/dL	22.4 (16.4; 28.9)	19 (14.5; 24)	-	0.0885
Albumin quotient, Q_Alb	0.0064 (0.0049; 0.0097)	0.005 (0.003; 0.006)	-	0.0002
Lactic acid, mmol/L	1.6 (1.5; 1.8)	-	1.7(1.5 ; 1.8)	0.6499
RBC, cells/mm³	0.5 (0; 7.5)	2.0 (1.0;4.0)	3.4(0.95;53)	0.0133
Log CSF HIV RNA	1.7 (1.7; 2.8)	-	-	-
Viral load < 50	35	-	-	-
HIV RNA CSF > blood, n(%)	12 (18)	-	-	-

CSF glucose was significantly higher in HIV-negative volunteers than in HIV participants, although levels in both groups were below reference range.

Data are presented as median (IQR) or number of cases (%).